In 2023, more than 3,500 Illinoisans died of opioid overdose.
To hold companies responsible for their roles in the opioid crisis, the Illinois Attorney General has engaged in multiple investigations, lawsuits, and settlements with opioid manufacturers, distributors, and chain pharmacies. The funds from the settlements will support recovery in communities hardest hit by the opioid crisis and throughout the state.1
Settlements Overview
The Illinois Attorney General, along with attorneys general for numerous other states, filed lawsuits against prescription opioid distributors, manufacturers, and dispensers to seek recovery for their unfair and deceptive practices in the marketing, sale, and distribution of these drugs. These lawsuits led to numerous national multistate settlement agreements with various participants in the prescription opioid market. As a result of these efforts, Illinois expects to receive more than $1.3 billion in settlement monies by 2038, to be used in all parts of the state to abate the opioid crisis.
National Opioids Settlement (nationalopioidsettlement.com)
Settlements Payments
March 2025
To date, national opioid settlements have been finalized with:
- Allergan
- AmerisourceBergen, Cardinal Health, and McKesson (Distributors)
- CVS
- Endo
- Kroger
- Mallinckrodt Pharmaceuticals
- Meijer+
-
Johnson & Johnson
- Publicis Health
- Teva Pharmaceuticals
- Walgreens
- Walmart
+ The Meijer settlement was entered into by certain Illinois counties only, with the monies being distributed in accordance with the Illinois Opioid Allocation Agreement.
*Information current as of March 1, 2025
Office of Opioid Settlements Administration Update
The Illinois Department of Human Services/Division of Substance Use Prevention and Recovery (IDHS/SUPR) and the Illinois Opioid Remediation Advisory Board (IORAB), in an effort to be transparent and accountable for the opioid settlement funds received, will annually publish a report of settlement funds received and distributed. The Illinois Remediation Funds State Fiscal Year 2024 Annual Report is available now.
March 2025
At its January 30, 2025 meeting, the Illinois Opioid Remediation Advisory Board (IORAB) reviewed and recommended two recommendations: Capital Investments and Overdose Prevention Sites. These recommendations were reviewed by the Governor’s Opioid Prevention and Recovery Steering Committee (Steering Committee) at its February 25, 2025 meeting. The Capital Investments recommendation was approved, but the Steering Committee requested additional formation for the Overdose Prevention Sites recommendation.
Capital Investments: $20 million
This recommendation, which will be a partnership between IDHS and another state agency, adds funding to the previously approved capital investment recommendation to build permanent supportive housing for individuals with opioid and other substance use disorders that also experience homelessness.
The next meeting of the IORAB will be April 24, 2025. More information is available on the IORAB web page. More information on future Steering Committee meetings is available on the Steering Committee web page.
About OOSA
Established by Executive Order 2022-19, the Illinois Office of Opioid Settlement Administration (OOSA) is the entity responsible for planning, administering, and managing 55% of the funds received from opioid settlements. The OOSA is housed within the Illinois Department of Human Services Division of Substance Use Prevention and Recovery.
The OOSA is dedicated to addressing the opioid crisis and employs resources to fund recommended and approved core abatement strategies for opioid settlement funds to combat the overdose epidemic as established in the Illinois Opioid Allocation Agreement (Allocation Agreement). These opioid core abatement strategies align with recommendations in the 2022 State of Illinois Overdose Action Plan (SOAP), a comprehensive, equity-centric outline for combatting the opioid epidemic.
The OOSA is led by the Statewide Opioid Settlement Administrator, who works collaboratively with the Illinois Opioid Remediation Advisory Board (IORAB) to develop non-binding funding recommendations to present to the Illinois Opioid Prevention and Recovery Steering Committee. The recommendations help ensure the state’s settlement portion in the trust (55%) is used for approved abatement strategies and equitably distributed across the state, taking into account the areas most impacted by the opioid epidemic. IORAB recommendations that are approved by the Steering Committee must be certified by the Attorney General’s office and processed in accordance with state requirements for funding opportunities.
For information on the IORAB, visit its webpage at Illinois Opioid Remediation Advisory Board.
Information for Local Governmental Units
“Local Government Units (LGs)” refers to the more than 200 Illinois counties and municipalities that are eligible to receive a direct distribution of settlement monies under the Allocation Agreement. LGs are required to use their opioid settlement distributions in accordance with the Allocation Agreement, and report their expenditures quarterly.
References
- Pritzker Administration Announces Illinois Overdose Deaths Declined 8% in 2023. Pritzker Administration Announces Illinois Overdose Deaths Declined 8% in 2023
- Executive Order 2022-19. (2022). Order regarding the administration of settlement proceeds received from Illinois’ opioid litigation and creating the Illinois Opioid Remediation Advisory Board and the Office of Opioid Settlement Administration https://www.illinois.gov/government/executive-orders/executive-order.executive-order-number-19.2022.html